October 10, 2008
For Immediate Release
Spine Surgery Technologies Demonstrating Robust Worldwide Market Growth and Market Evolution; Report from MedMarket Diligence, LLC
Among the most device-intensive healthcare markets, the spine surgery market has been undergoing dramatic changes as numerous new technologies take hold in the well established spine surgery surgical arena and manufacturers continue to develop new technologies and roll them out for a growing patient population. Globally, the market will grow to over $26 billion over the next ten years, demonstrating double digit growth in the process. The MedMarket Diligence report on spine surgery details the products, technologies, markets and companies worldwide.
Foothill Ranch, CA -- October 10, 2008 -- The practice of spine surgery has until recently been characterized by a dominance of spine fusion procedures, but due to the shortcomings of the technologies in terms of invasiveness and less than ideal clinical outcomes, new technologies encompassing dynamic stabilization, disc replacement and the use of other products like interspinous processes and orthopedic biomaterials are displacing caseload in spine fusion. The global market for spine surgery will therefore continue to be characterized by changing caseload, introduction of new technologies and, most importantly, solid market growth -- in double digit terms -- for at least ten years. The worldwide spine surgery market is detailed in the 2008 report from MedMarket Diligence, described here.
"Spine surgery represents an unusually strong market opportunity in the medical technology industry," says Patrick Driscoll, President of MedMarket Diligence, LLC. "Since the spine serves such a structural function for the body, device technologies are exceptional in solving structural problems like degenerative disc disease, spinal trauma and other mechanical disorders of the spine, and as the population swells in the over 65 bracket, the demand keeps increasing --- the striking number of new spine surgery companies founded in the last several years is testimony enough to the potential in this market."The MedMarket Diligence report #M510 is a detailed market and technology assessment and forecast of the products and technologies in the management of diseases and disorders of the spine. The report describes diseases and disorders of the spine, encompassing congenital disorders, inflammatory and infectious diseases; degenerative diseases; herniations, stenoses, myelopathies and other "mechanical" disorders of the spine; spinal trauma; tumors of the spine; and others. The report characterizes the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. The report details the currently available products and technologies, and manufacturer offerings. The report details products and technologies under development and markets for each in spine surgery. The report provides a current and forecast assessment of the worldwide markets for these technologies, with geographic segmentation by U.S. & Canada, European Union (detailing France, United Kingdom, Germany, Italy and Spain), Japan and Rest of World. The report provides emphasis on the market impact of new technologies through the coming decade, profiling nealry 100 active companies in this industry, with comprehensive detail on key companies, providing data on their current products, current market position and products under development.
About MedMarket Diligence
Patrick Driscoll founded MedMarket Diligence in October 2001. Mr. Driscoll has over 20 years experience analyzing and writing on medical technology markets, encompassing medical devices, biotech and biopharmaceuticals. He was co-founder of Medtech Insight and prior to that, a principal at Medical Data International, and in these organizations built syndicated reports businesses and directed the companies' custom consulting activities. Mr. Driscoll received a BS from the University of Dallas, and an MBA from the University of New Hampshire's Whittemore School of Business & Economics. Email: patrick[at]mediligence[dot]com.
Dona Watson is the Managing Editor of MedMarkets. Ms. Watson has an
extensive editorial background and focus serving the information needs of the
medical technology industry. She has served in editorial, analyst and
writer positions for the MedPro Month publication of Medical Data International,
as well as Nicholas Communications, and Biomedical Business International.
In addition, Ms. Watson was president of Catalyst Communications, where she was
publisher for an industry newsletter devoted to reimbursement of medical
products. Ms. Watson received a BA from Vanguard University. Email:
© 2001- MedMarket Diligence, LLC. All rights reserved.